The main market of the London Stock Exchange has embraced its first medicinal cannabis companies, but things were very different a few years ago. This article introduces the popular newcomers to the main market of the London stock exchange, its larger international peers and market peculiarities of this wacky sector.
Earlier in the month, MGC Pharmaceuticals (LON:MXC) became the first medicinal cannabis company to be listed on the main market of the London Stock Exchange.
GW Pharmaceuticals (GWPH), a developer of marijuana-based epilepsy treatments, was previously listed on AIM but delisted in 2016 due to a general lack of interest in its shares from UK investors. At the time of its delisting GW said that 78% of its shares were held as ADRs on the Nasdaq…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.